Zobrazeno 1 - 10
of 963
pro vyhledávání: '"Yoshio Hayashi"'
Autor:
Hiroaki Miyauchi, Koshu Okubo, Kiriko Iida, Hiroshi Kawakami, Kentaro Takayama, Yoshio Hayashi, Junji Haruta, Junichi Sasaki, Kaori Hayashi, Junichi Hirahashi
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Crush syndrome, which frequently occurs in earthquake disasters, often leads to rhabdomyolysis induced acute kidney injury (RIAKI). Recent findings indicate that systemic inflammatory response syndrome (SIRS) exacerbates muscle collapse, contributing
Externí odkaz:
https://doaj.org/article/2a61a59683c848548f7783e09a80f5f8
Publikováno v:
Pharmaceuticals, Vol 16, Iss 3, p 397 (2023)
Sarcopenia is a major public health issue that affects older adults. Myostatin inhibitory-D-peptide-35 (MID-35) can increase skeletal muscle and is a candidate therapeutic agent, but a non-invasive and accessible technology for the intramuscular deli
Externí odkaz:
https://doaj.org/article/8a506897109947f2b6f7104b334ec1af
Autor:
Hayate Shida, Akihiro Taguchi, Sho Konno, Kentaro Takayama, Atsuhiko Taniguchi, Yoshio Hayashi
Publikováno v:
Chemical and Pharmaceutical Bulletin. 71:435-440
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::737ac3c3c1a1bd80070a18fcff4bf5f2
https://doi.org/10.1248/cpb.c23-00087
https://doi.org/10.1248/cpb.c23-00087
Autor:
Kyohei Muguruma, Konomi Fujita, Akane Fukuda, Satoshi Kishimoto, Soichiro Sakamoto, Risako Arima, Mayu Ito, Mayu Kawasaki, Shogo Nakano, Sohei Ito, Kanade Shimizu, Akihiro Taguchi, Kentaro Takayama, Atsuhiko Taniguchi, Yuji Ito, Yoshio Hayashi
Publikováno v:
ACS Omega, Vol 4, Iss 11, Pp 14390-14397 (2019)
Externí odkaz:
https://doaj.org/article/86504a125b354796878b3cd771ed76b5
Autor:
Hironobu Murakami, Yuuta Fujikawa, Masaya Mori, Nozomi Mosu, Akihiro Taguchi, Yoshio Hayashi, Hideshi Inoue, Shinji Kamisuki
Publikováno v:
Bioscience, Biotechnology & Biochemistry; Sep2023, Vol. 87 Issue 9, p946-953, 8p
Autor:
Hideyuki Okamoto, Shuko Amber Murano, Kaoru Ikekawa, Masahiro Katsuyama, Sho Konno, Akihiro Taguchi, Kentaro Takayama, Atsuhiko Taniguchi, Yoshio Hayashi
Publikováno v:
RSC Medicinal Chemistry. 14:386-392
Myostatin-binding d-peptides functionalized with photocatalyst efficiently inactivate myostatin by photooxygenation and show no phototoxicity and high resistance to proteolytic enzymes, leading to the treatment of muscular atrophic diseases.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73c442d5b725c15e6bb798137ca3442e
https://doi.org/10.1039/d2md00425a
https://doi.org/10.1039/d2md00425a
Autor:
Yan Cui, Akihiro Taguchi, Hayate Shida, Sho Konno, Kentaro Takayama, Atsuhiko Taniguchi, Yoshio Hayashi
Publikováno v:
Bulletin of the Chemical Society of Japan. 95:1156-1162
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bf9c1a8a6da001af3230e51cfef3228
https://doi.org/10.1246/bcsj.20220103
https://doi.org/10.1246/bcsj.20220103
Autor:
Kentaro Takayama, Keisuke Hitachi, Hideyuki Okamoto, Mariko Saitoh, Miki Odagiri, Rina Ohfusa, Takahiro Shimada, Akihiro Taguchi, Atsuhiko Taniguchi, Kunihiro Tsuchida, Yoshio Hayashi
Publikováno v:
ACS Med Chem Lett
[Image: see text] Myostatin is a key negative regulator of skeletal muscle growth, and myostatin inhibitors are attractive tools for the treatment of muscular atrophy. Previously, we reported a series of 14–29-mer peptide myostatin inhibitors, incl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e40cd8654e1843fc3cf77724b94de2fd
https://doi.org/10.1021/acsmedchemlett.1c00705
https://doi.org/10.1021/acsmedchemlett.1c00705
Publikováno v:
Practica oto-rhino-laryngologica. Suppl.. 158:119-121
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad9ce47b7670afb27bdcc16a237613e9
https://doi.org/10.5631/jibirinsuppl.158.119
https://doi.org/10.5631/jibirinsuppl.158.119
Autor:
Kako Hanada, Kunpei Fukasawa, Hiroki Hinata, Shú Imai, Kentaro Takayama, Hideyo Hirai, Rina Ohfusa, Yoshio Hayashi, Fumiko Itoh
Publikováno v:
Cancer science. 113(10)
Cancer cachexia is a multifactorial disease that causes continuous skeletal muscle wasting. Thereby, it seems to be a key determinant of cancer-related death. Although anamorelin, a ghrelin receptor agonist, has been approved in Japan for the treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99a9e69719a69100a093dc3d7e5b6c8b
https://pubmed.ncbi.nlm.nih.gov/35849084
https://pubmed.ncbi.nlm.nih.gov/35849084